New-onset diabetes and risk of all-cause and cardiovascular mortality: The cardiovascular health study

Diabetes Care

Volumn 29, Issue 9, 2006, Pages 2012-2017

  Smith, Nicholas L ^a,c   Barzilay, Joshua I ^b   Kronmal, Richard ^a   Lumley, Thomas ^a   Enquobahrie, Daniel ^a   Psaty, Bruce M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b KAISER PERMANENTE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE;

AGED; ARTICLE; ATHEROSCLEROSIS; ATTRIBUTABLE RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HAZARD ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; QUESTIONNAIRE; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SURVIVAL;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 33845323754     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-0574     Document Type: Article

References (24)

1. Natarajan S, Liao Y, Sinha D, Cao G, McGee DL, Lipsitz SR: Sex differences in the effect of diabetes duration on coronary heart disease mortality. Arch Intern Med 165:430-435, 2005
2. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 21:518-524, 1998
3. Centers for Disease Control and Prevention (CDC): Trends in the prevalence and incidence of self-reported diabetes mellitus: United States, 1980-1994. MMWR Morb Mortal Wkly Rep 46:1014-1018, 1997
4. Burke JP, O'Brien P, Ransom J, Palumbo PJ, Lydick E, Yawn BP, Joseph Melton L 3rd, Leibson CL: Impact of case ascertainment on recent trends in diabetes incidence in Rochester, Minnesota. Am J Epidemiol 155:859-865, 2002
5. Ubink-Veltmaat LJ, Bilo HJ, Groenier KH, Houweling ST, Rischen RO, Meyboom-de Jong B: Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in The Netherlands (ZODIAC-1). Eur J Epidemiol 18:793-800, 2003
6. Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K: Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161:397-405, 2001
7. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A, et al.: The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1:263-276, 1991
8. Tell GS, Fried LP, Hermanson B, Manolio TA, Newman AB, Borhani NO: Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol 3:358-366, 1993
9. Psaty BM, Lee M, Savage PJ, Rutan GH, German PS, Lyles M: Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study: the Cardiovascular Health Study Collaborative Research Group. J Clin Epidemiol 45:683-692, 1992
10. Ives DG, Fitzpatrick AL, Bild DE, Psaty BM, Kuller LH, Crowley PM, Cruise RG, Theroux S: Surveillance and ascertainment of cardiovascular events: the Cardiovascular Health Study. Ann Epidemiol 5:278-285, 1995
11. Psaty BM, Kuller LH, Bild D, Burke GL, Kittner SJ, Mittelmark M, Price TR, Rautaharju PM, Robbins J: Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol 5:270-277, 1995
12. Folsom AR, Szklo M, Stevens J, Liao F, Smith R, Eckfeldt JH: A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 20:935-942, 1997
13. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234, 1998
14. Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, Wilson PW: Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 290:891-897, 2003
15. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33): UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:837-853, 1998
16. Wei M, Gaskill SP, Haffner SM, Stern MP: Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality: the San Antonio Heart Study. Diabetes Care 21:1167-1172, 1998
17. Laakso M: Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 48:937-942, 1999
18. Smith NL, Barzilay JI, Shaffer D, Savage PJ, Heckbert SR, Kuller LH, Kronmal RA, Resnick HE, Psaty BM: Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study. Arch Intern Med 162:209-216, 2002
19. Sheetz MJ, King GL: Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA 288:2579-2588, 2002
20. Creager MA, Luscher TF, Cosentino F, Beckman JA: Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation 108:1527-1532, 2003
21. Qiao Q, Dekker JM, de Vegt F, Nijpels G, Nissinen A, Stehouwer CD, Bouter LM, Heine RJ, Tuomilehto J: Two prospective studies found that elevated 2-hr glucose predicted male mortality independent of fasting glucose and HbA1c. J Clin Epidemiol 57:590-596, 2004
22. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643-2653, 2005
23. Turner R, Holman R, Stratton I, Cull C, Frighi V, Manley S, Matthews D, Neil A, McElroy H, Kohner E, Fox C, Hadden D, Wright D: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38: UK Prospective Diabetes Study Group. BMJ 317:703-713, 1998
24. Smith NL, Savage PJ, Heckbert SR, Barzilay JI, Bittner VA, Kuller LH, Psaty BM: Glucose, blood pressure, and lipid control in older people with and without diabetes mellitus: the Cardiovascular Health Study. J Am Geriatr Soc 50:416-423, 2002